Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.74%
1,094.84
+18.71
+1.74%
1,076.131,079.891,100.771,079.89
SIXC
Communications
SIXC
Communications
SIXC
-0.42%
604.21
-2.53
-0.42%
606.74606.74607.90602.03
SIXE
Energy
SIXE
Energy
SIXE
+0.07%
1,249.71
+0.89
+0.07%
1,248.821,246.371,256.421,239.08
SIXI
Industrials
SIXI
Industrials
SIXI
+0.86%
1,739.26
+14.90
+0.86%
1,724.361,733.021,745.751,727.76
SIXM
Financials
SIXM
Financials
SIXM
+0.01%
635.63
+0.040
+0.01%
635.59635.08637.96633.31
SIXR
Staples
SIXR
Staples
SIXR
+0.61%
848.32
+5.17
+0.61%
843.15842.50852.77840.85
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.22%
216.76
+0.47
+0.22%
216.29216.29217.30215.24
SIXT
Technology
SIXT
Technology
SIXT
+2.20%
3,335.14
+71.73
+2.20%
3,263.413,296.253,343.663,295.42
SIXU
Utilities
SIXU
Utilities
SIXU
+0.01%
939.34
+0.10
+0.01%
939.24941.57948.11939.11
SIXV
Health care
SIXV
Health care
SIXV
+0.38%
1,468.17
+5.61
+0.38%
1,462.561,465.031,471.561,459.66
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.28%
2,387.09
+6.69
+0.28%
2,380.402,394.922,412.132,386.82
C5G:FRA
Orexo AB
€1.75
+5.54%
(+0.092) 1D
May 6, 8:03:49 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C5G...
Open
€1.75
High
€1.75
Low
€1.75
Mkt. cap
675.14M
Avg. vol.
0.00
Volume
0.00
52-wk high
€3.82
52-wk low
€1.20
No. of employees
74
News stories
From sources across the web
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees74
Founded1995
Headquarters-
SectorPharmaceutical industry
Websiteorexo.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
118.20M
118.70M
3.30M
5.00M
Cost of goods sold
8.40M
7.10M
2.60M
500.00K
Cost of revenue
8.40M
7.10M
2.60M
500.00K
Research and development expenses
57.20M
61.70M
55.60M
50.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71.10M
71.90M
28.00M
37.40M
Operating expense
128.10M
132.51M
80.70M
79.50M
Total operating expenses
136.50M
139.61M
83.30M
80.00M
Operating income
-18.30M
-20.91M
-80.00M
-75.00M
Other non operating income
-500.00K
-200.00K
-200.00K
-
EBT including unusual items
-33.90M
-32.70M
-115.50M
-104.20M
EBT excluding unusual items
-34.50M
-32.71M
-93.50M
-104.20M
Income tax expense
5.90M
-2.90M
100.00K
1.00M
Effective tax rate
-17.40%
8.87%
-0.09%
-0.96%
Other operating expenses
-200.00K
-1.09M
-2.90M
-8.00M
Net income
-39.80M
-29.80M
724.80M
-133.90M
Net profit margin
-33.67%
-25.11%
21,963.64%
-2,678.00%
Earnings per share
-1.15
-
-
-
Interest and investment income
300.00K
800.00K
600.00K
-
Interest expense
-12.00M
-11.30M
-12.20M
-29.20M
Net interest expenses
-11.70M
-10.50M
-11.60M
-29.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.90M
-9.61M
-46.80M
-63.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more